Dr. Speliotes is the Keith Henley Endowed Professor of Gastroenterology and Computational Medicine and Bioinformatics at the University of Michigan. She is an internationally leader in the genetics of human obesity, MASLD, and cardiometabolic disease having identified thousands of genetic variants that cause these diseases. She developed bioinformatic methods to identify causal tissues, genes and pathways highlighted by genomic analyses.
Dr. Ouyang's Lab investigates how metabolic and oxidative stress regulate immune responses, focusing on post-transcriptional regulation in RNA metabolism, protein trafficking, and organelle dynamics in chronic inflammation. It aims to identify cellular effectors and metabolic regulators that maintain liver homeostasis and contribute to chronic liver disease including MASH, ASH, and HCC
Elizabeth Lee is a nurse practitioner at the Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network (UHN) in Toronto, Canada. She has worked for over 16 years in various clinical settings in the community and within UHN, spanning the continuum of chronic liver disease from diagnosis to transplantation.<br><br>Her main clinical focus is on the management of patients with cirrhosis and alcohol-associated liver disease (ALD).
Dr. Vos is a professor of pediatrics and vice chair of clinical research for the Department of Pediatrics at Emory and Children's Healthcare of Atlanta. She has studied MASLD in children for over 20 years, leading to improved dietary approaches and advancing the understanding of biomarkers.
Dr. Yokoo is an abdominal radiologist and the Medical Director of MRI at University of Texas Southwestern in Dallas, TX. He completed his diagnostic radiology residency at University of California at San Diego, and abdominal imaging and intervention fellowship at Massachusetts General Hospital. He serves as the radiology co-chair for Congestive Hepatopathy Working Group for Liver Imaging Reporting and Data System (LI-RADS) of American College of Radiology.
Dr. Michalopoulos is Distinguished Professor of Pathology, University of Pittsburgh. He was at the leading edge of the studies associated with the discovery of HGF (Hepatocyte Growth Factor) and its receptor (c-Met). His research covers molecular events involving growth factor and biomatrix signaling during liver regeneration; the capacity of hepatocytes and cholangiocytes to function as facultative stem cells for each other. <br><br>He is a member of AASLD since 1985.
Second year GI Fellow at VCU in Richmond, VA
I grew up in suburban Chicagoland, completed undergrad at Earlham College in Richmond Indiana, attended medical school at University of Michigan on a US Air Force scholarship, completed combined Anatomic & Clinical Pathology residency at University of Chicago followed by four years of active duty service as a staff pathologist in the military at Wright-Patterson Air Force Base outside Dayton Ohio, then separated from the military and returned to University of Chicago for a one-year gastrointestinal & hepatic pathology fellowship, and in Aug 2025 joined faculty at Duke University as
PGY-3 in Internal Medicine at Mayo Clinic, Rochester.